9th meeting held for external reference pricing reevals
By Lee, Tak-Sun | translator Kang, Shin-Kook
24.06.13 05:32:02
°¡³ª´Ù¶ó
0
Government¡¯s proposal to use the A8 average price excluding the highest-lowest price will remain as is
Disagreement on which drugs should be excluded from revaluation, method of searching overseas drug prices, the lower limit for markdowns, etc.
The government and the pharmaceutical industry held the 9th meeting on external reference pricing reevaluations but reportedly decided to continue discussions.
Initially, the 9th meeting was supposed to be the last in the opinion-gathering process, but further meetings were deemed inevitable.
According to industry sources, the government and the pharmaceutical industry held the 9th round of talks on the external reference pricing reevaluations at the Kukje Electronic Center in Seocho-gu on the 12th.
This is the 9th round of talks since it began in November last year. As the government¡¯s proposal for the method of comparison came out at the 8th meeting, the 9
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)